Compared to clonal IDH-mutant astrocytomas (n = 156), subclonal cases demonstrated worse overall survival in grades 3 (P = .0106) and 4 (P = .0184). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).